
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
Author(s) -
Menzies-Gow AN,
Claire N. McBrien,
Bindhu Unni,
Porsbjerg CM,
Mona AlAhmad,
Christopher S. Ambrose,
Dahl Assing K,
von Bülow A,
John Busby,
Borja G. Cosío,
FitzGerald Jm,
Garcia Gil E,
Susanne Hansen,
Heaney LG,
Hew M,
Dana L. Jackson,
Maria Kallieri,
Stelios Loukides,
Lugogo NL,
Papaioannou AI,
Désiree LarenasLinnemann,
Moore WC,
Perez-de-Llano LA,
Rasmussen LM,
Johannes Martin Schmid,
Salman Siddiqui,
Marianna Alacqua,
Tran TN,
Suppli Ulrik C,
Upham JW,
E Wang,
Lakmini Bulathsinhala,
Carter VA,
Isha Chaudhry,
Neva Eleangovan,
Murray RB,
Price CA,
Price DB
Publication year - 2022
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s328653
Subject(s) - medicine , asthma , omalizumab , discontinuation , exacerbation , pediatrics , immunology , immunoglobulin e , antibody